← Scroll for more →
Financial Statements — NERV
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 24.65 | 32.66 | 82.30 | 12.29 | 15.25 | 17.29 | 21.36 | 26.53 | 30.88 | 34.82 | 40.91 | 46.90 | 51.80 | 35.98 | 36.09 | 40.22 | 49.75 | 54.95 | 60.76 | 65.59 |
| Short-term Investments | 50.62 | 45.41 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | 79.73 | 79.11 | 83.10 | 13.02 | 15.55 | 17.92 | 22.27 | 27.94 | 31.41 | 35.62 | 42.00 | 48.23 | 52.23 | 36.67 | 40.16 | 44.84 | 50.04 | 55.70 | 62.20 | 67.44 |
| Property, Plant & Equipment | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | -- | -- | -- | -- | -- |
| Goodwill | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 15.20 |
| Total Non-current Assets* | 15.36 | 14.92 | 14.87 | 15.07 | 14.87 | 14.87 | 14.87 | 14.88 | 14.88 | 14.89 | 14.90 | 14.91 | 14.91 | 14.92 | 14.93 | 14.92 | 14.92 | 14.92 | 14.92 | 30.12 |
| Total Assets | 95.09 | 94.03 | 97.97 | 28.09 | 30.42 | 32.80 | 37.14 | 42.81 | 46.29 | 50.51 | 56.90 | 63.13 | 67.14 | 51.59 | 55.09 | 59.76 | 64.96 | 70.62 | 77.12 | 97.56 |
| Accounts Payable | 1.45 | 2.12 | 0.64 | 0.94 | 0.90 | 0.64 | 1.61 | 0.55 | 0.83 | 1.44 | 1.81 | 1.40 | 0.30 | 0.96 | 0.97 | 0.53 | 1.52 | 1.59 | 1.85 | 1.20 |
| Total Current Liabilities | 3.96 | 4.48 | 2.29 | 2.67 | 2.53 | 1.95 | 2.84 | 4.48 | 4.20 | 2.83 | 3.34 | 3.35 | 1.91 | 2.50 | 1.38 | 2.20 | 3.41 | 3.25 | 2.82 | 3.08 |
| Total Non-current Liabilities* | 292.69 | 338.60 | 231.46 | 60.00 | 60.00 | 60.00 | 60.00 | 60.00 | 86.58 | 84.27 | 82.02 | 79.83 | 77.74 | 75.71 | 73.73 | 71.81 | 69.93 | 68.11 | 66.33 | 66.40 |
| Total Liabilities | 296.65 | 343.08 | 233.76 | 62.67 | 62.53 | 61.95 | 62.84 | 64.48 | 90.78 | 87.10 | 85.36 | 83.18 | 79.65 | 78.21 | 75.11 | 74.00 | 73.34 | 71.35 | 69.15 | 69.48 |
| Retained Earnings | (796.74) | (814.20) | (688.80) | (405.13) | (402.39) | (399.13) | (395.38) | (391.10) | (413.62) | (405.38) | (396.82) | (387.79) | (379.97) | (373.78) | (366.81) | (360.08) | (353.18) | (344.47) | (334.70) | (313.39) |
| Total Stockholder Equity | (213.30) | (254.01) | (140.75) | (34.58) | (32.11) | (29.15) | (25.69) | (21.67) | (44.49) | (36.59) | (28.46) | (20.05) | (12.51) | (26.62) | (20.02) | (14.25) | (8.38) | (0.74) | 7.98 | 28.08 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 |
| Research & Development | 7.19 | 5.25 | 2.17 | 0.93 | 1.30 | 1.36 | 1.98 | 1.89 | 3.86 | 4.17 | 4.72 | 3.44 | 1.89 | 2.65 | 3.19 | 2.37 | 4.13 | 4.96 | 18.75 | 4.51 |
| Selling, General & Admin | 3.45 | 11.42 | 2.81 | 1.92 | 2.08 | 2.54 | 2.54 | 2.48 | 2.42 | 2.51 | 2.45 | 2.64 | 2.63 | 2.69 | 1.88 | 2.84 | 2.83 | 3.03 | 2.63 | 3.00 |
| Total Operating Expenses | 10.64 | 16.67 | 4.98 | 2.84 | 3.37 | 3.90 | 4.52 | 4.37 | 6.28 | 6.68 | 7.17 | 6.08 | 4.52 | 5.35 | 5.07 | 5.21 | 6.97 | 7.99 | 21.38 | 7.52 |
| Operating Income | (10.64) | (16.67) | (4.98) | (2.84) | (3.37) | (3.90) | (4.52) | (4.37) | (6.28) | (6.68) | (7.17) | (6.08) | (4.52) | (5.35) | (5.07) | (5.21) | (6.97) | (7.99) | (21.38) | (7.52) |
| Net Income | 17.47 | (125.40) | (283.67) | (2.74) | (3.26) | (3.75) | (4.27) | 22.51 | (8.23) | (8.57) | (9.02) | (7.82) | (6.19) | (6.97) | (6.73) | (6.90) | (8.72) | (9.76) | (21.31) | (9.21) |
| Basic EPS | 0.36 | (2.86) | (33.38) | (0.36) | (0.43) | (0.50) | (0.56) | 2.97 | (1.09) | (1.13) | (1.15) | (1.03) | (1.12) | (1.31) | (1.26) | (1.29) | -- | -- | (0.50) | (0.22) |
| Diluted EPS | (0.14) | (2.86) | (33.38) | (0.36) | (0.43) | (0.50) | (0.56) | 2.97 | (1.09) | (1.13) | (1.15) | (1.03) | (1.12) | (1.31) | (1.26) | (1.29) | -- | -- | (0.50) | (0.22) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (13.34) | (5.43) | (4.48) | (2.92) | (2.04) | (4.07) | (5.17) | (4.35) | (3.94) | (6.09) | (5.99) | (4.81) | (3.87) | (0.12) | (4.11) | (9.53) | (5.19) | (5.81) | (4.83) | (8.63) |
| Investing Cash Flow | (4.83) | (45.29) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- | 0.00 | 0.00 | 0.00 | -- | -- | -- | -- | -- | -- |
| Financing Cash Flow | 10.17 | 1.08 | 74.50 | (0.05) | 0.00 | 0.00 | -- | -- | -- | 0.00 | 0.00 | (0.09) | 19.69 | 0.00 | 0.00 | 0.00 | -0.00 | -- | 0.00 | 0.00 |
← Scroll for more columns →